Skip to content

A preliminary investigation into the impact of military lifestyle on the gut microbiome

A preliminary investigation into the impact of military lifestyle on the gut microbiome (MAST-Microbiome Adaptations to Soldier Training)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN15616239
Enrollment
60
Registered
2025-04-11
Start date
2023-05-08
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observed changes in the gut microbiome of officer cadet's performance Digestive System

Interventions

This is a prospective observational cohort study that will follow service personnel across 44 weeks to identify the impact of adopting a military lifestyle on the gut microbiome and its response to mi

Sponsors

Defence Science and Technology Laboratory
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Officer Cadets joining the Commissioning Courses in April/May or September 2023, or January 2024 2. No use of GI (Gastro-Intestinal) medications (e.g., laxatives, stool-softeners or antidiarrheals) 3. No probiotic use within last 3 months (probiotic enriched foods such as yoghurts are fine) 4. No GI (Gastro-Intestinal) related procedures in the past 3 months (Including enema, colonoscopy) 5. No antibiotic use within last 6 months 6. No known GI (Gastro-Intestinal)- related diseases, or major medical issues 7. No/limited previous military experience (training or active service for >6 consecutive months, and within 6 months of the training start date) 8. Able to give informed consent and collect stool samples

Exclusion criteria

Exclusion criteria: 1. Short term use of prescribed medication, where use is likely to or may change before the end of the study (next 44 weeks/11 months) 2. Infrequent bowel movement (fewer than 3 bowel movements a week) 3. Known to be pregnant

Design outcomes

Primary

MeasureTime frame
Microbial Composition: Changes in microbiome structure and predicted function measured by whole genome DNA sequencing of longitudinal samples collected at 0, 14, 29, 39, and 42 weeks

Secondary

MeasureTime frame
1. Correlation of wellbeing outcomes with blood biomarkers and performance outcomes will be performed using the following measures: 1.1. Symptoms of depression, anxiety, and stress are measured using the Depression Anxiety and Stress Scale 21 (DASS-21) at weeks 0, 14, 29, and 42. 1.2. Sleep quality is measured using the Pittsburgh Sleep Quality Index (PSQI) at weeks 0, 14, 29, and 42. 1.3. Cognitive performance measured using a cognitive battery of tests (Reaction time (RTI) and Spatial Working Memory (SWM)) at weeks 0, 29, and 42. 1.4. Physical performance data recorded through routine fitness tests conducted as part of normal training (including 2km run, deadlift, and medicine ball throw) at weeks 0, 14 and 29. 1.5. Blood biomarkers (CRP, IL-6, Cortisol, LBP) measured using a mix of lab-based methods (ELISA, flow cytometry, Randox) at weeks 0, 14, 29, and 42 weeks 2. The feasibility of gut microbiome studies will be assessed within UK military populations using the following measures: 2.1. Subjective feedback from participants about barriers to compliance and recruitment measured using a qualitative questionnaire at the end of the study and reported to inform future research. 2.2. Sample attrition and uptake success measured using data recorded throughout the study

Countries

England, United Kingdom

Contacts

Public ContactRosie ;Simon Young;Carding

;

rosie.young@quadram.ac.uk;simon.carding@quadram.ac.uk+44 (0)1603 255000 Ext. 5007 ;+44 (0)1603 255000 Ext. 1410

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026